You’re on our free tier. Upgrade to NewsNow Essentials now and get your favourite news platform, faster, slicker and ads free.You’re on our free tier. Upgrade to NewsNow Essentials now. Faster, slicker and ads free.You’re on our free tier. Upgrade and go ads free now!

Home
Hot Topics
UK
World
Gaza
Ukraine
Iran
Climate Crisis
Business
Football
Sport
Entertainment
Tech
Science

AstraZeneca
Pharmaceuticals
Sanofi
GSK
Novartis
AbbVie
Pfizer
Bristol Myers Squibb
Novo Nordisk
Valneva
Johnson and Johnson
Topics

Advertisement

AstraZeneca

Share

Top Latest Popular

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

NewsNow Essentials. Your favourite news platform, ads free. Upgrade now!

AstraZeneca warns German reforms could push pharma launches and investment out of Europe EU Reporter 1d

EU Reporter 1d

Global drug company AstraZeneca ‘hacked’ by teenage cyber gang Metro.co.uk 1d

Metro.co.uk 1d

AstraZeneca launches Lokelma in Korea to prevent drop-off from key heart and kidney drugs Korea Biomedical Review 2d

Korea Biomedical Review 2d

AstraZeneca’s Ultomiris Hits Interim Phase III Endpoint In IgAN, Eyes Accelerated Filings Scrip Pharma Intelligence 3d

Scrip Pharma Intelligence 3d

Advertisement

AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win FiercePharma 3d

FiercePharma 3d

AstraZeneca (AZN) suffers a larger drop than the general market: Key insights Zacks 15h

Zacks 15h

Advertisement

Advertisement

Latest

In the last 6 hours

Former AstraZeneca offices sold to Oeiras International School Portugal Resident 08:56

In the last 8 hours

GSK doubles down on oncology as AstraZeneca’s pipeline cranks up Investors Chronicle 08:32

Earlier Today

Astrazeneca (AZN) Suffers a Larger Drop Than the General Market: Key Insights Zacks 00:19

Yesterday

Global drug company AstraZeneca ‘hacked’ by teenage cyber gang Metro.co.uk 16:38 Thu, 23 Apr

AstraZeneca warns German reforms could push pharma launches and investment out of Europe EU Reporter 08:20 Thu, 23 Apr

Wednesday

AstraZeneca to seek accelerated approval of Ultomirisin in IgAN on Phase III data Clinical Trials Arena 14:50 Wed, 22 Apr

AstraZeneca launches Lokelma in Korea to prevent drop-off from key heart and kidney drugs Korea Biomedical Review 11:06 Wed, 22 Apr

Tuesday

AstraZeneca's Ultomiris Meets Goal in Rare Kidney Disease Study Zacks 17:22 Tue, 21 Apr

AstraZeneca’s Ultomiris Hits Interim Phase III Endpoint In IgAN, Eyes Accelerated Filings Scrip Pharma Intelligence 15:53 Tue, 21 Apr

AstraZeneca eyes 5th Ultomiris indication after kidney disease trial win FiercePharma 15:52 Tue, 21 Apr

Advertisement

Advertisement

Advertisement

Advertisement

About our AstraZeneca news

Latest news on AstraZeneca, an Anglo-Swedish multinational pharmaceutical and biotechnology company based in Cambridge, with live updates on products and research.

NewsNow

Our Sites

NewsNow Nigeria

NewsNow România

NewsNow Australia

Work with us

Publisher Network

Dockside Online IDE

Legal

Subscription Terms

© Copyright 1997 - 2026 NewsNow Publishing Limited. All rights reserved.

Back to Industry Sectors Pharmaceuticals
- Abbott Laboratories
- AbbVie AbbVie
- AstraZeneca
- Baxter Baxter
- Bayer Bayer
- Boehringer Ingelheim
- Bristol Myers Squibb
- Eli Lilly Eli Lilly
- Genentech Genentech
- GlaxoSmithKline
- Johnson and Johnson
- Merck and Co
- Novartis Novartis
- Novavax Novavax
- Novo Nordisk
- Pfizer Pfizer
- Roche Roche
- Sanofi Sanofi
- Shire Shire
- Takeda Takeda
- Teva Teva
- Valneva Valneva
- Zoetis Zoetis